![Pia Baumann](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 70 149 $ al 30/06/2026
Pia Baumann currently works at Medivir AB, as Chief Medical Officer from 2023.
Dr. Baumann also formerly worked at AstraZeneca PLC, as Vice President-Medical.
Dr. Baumann received her doctorate degree from Karolinska Institutet.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
MEDIVIR AB 0,07 % | 05/03/2026 | 384.000 ( 0,07 % ) | 70 149 $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| MEDIVIR AB | Director Técnico/Científico/I+D | 20/02/2023 |
| Empresas | Cargo | Fin |
|---|---|---|
| ASTRAZENECA PLC | Director Técnico/Científico/I+D | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 3 |
|---|---|
AstraZeneca PLC
 AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Medivir AB
 Medivir AB Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Karolinska Institutet
 Karolinska Institutet Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
